Serial analysis of gene expression to assess the endothelial cell response to an atherogenic stimulus

Gene

Volumn 226, Issue 1, 1999, Pages 1-8

  De Waard, Vivian ^a   Van Den Berg, Birgit M M ^a   Veken, Jeroen ^a   Schultz Heienbrok, Robert ^a   Pannekoek, Hans ^a   Van Zonneveld, Anton Jan ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Activin; Atherosclerosis; Cell activation; SAGE

Indexed keywords

ACTIVIN; MESSENGER RNA;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; UNINDEXED SEQUENCE;

ACTIVINS; ARTERIOSCLEROSIS; CELLS, CULTURED; E-SELECTIN; ENDOTHELIUM, VASCULAR; EXPRESSED SEQUENCE TAGS; GENE EXPRESSION REGULATION; GENETIC TECHNIQUES; GROWTH SUBSTANCES; HUMANS; INHIBINS; INTERLEUKIN-8; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA, MESSENGER; TRANSCRIPTION, GENETIC; UMBILICAL VEINS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0033534773     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(98)00577-0     Document Type: Article

References (33)

1. Adams M.D., Kerlavage A.R., Fleischmann R.D., Fuldner R.A., Bult C.J., Lee N.H., Kirkness E.F., Weinstok K.G., Gocayne J.D., White O.et al. Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence. Nature. 377:1995;3-174.
2. Bevilacqua M.P., Stengelin S., Gimbrone M.A. Jr., Seed B. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science. 243:1989;1160-1165.
3. Boerde M., Roos D. Metabolic comparison between basophils and other leukocytes from human blood. J. Immunol. 136:1986;3447-3454.
4. Brand K., Page S., Rogler G., Bartsch A., Brandl R., Knuechel R., Page M., Kalschmidt C., Baeuerle P.A., Neumeier D. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J. Clin. Invest. 97:1996;1715-1722.
5. Carmeliet P., Moons L., Lijnen R., Janssens S., Lupu F., Collen D., Gerard R.D. Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: a gene targeting and gene transfer study in mice. Circulation. 96:1997;3180-3191.
6. Collins T. Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion. Lab. Invest. 68:1993;499-508.
7. Deng G., Curriden S.A., Wang S., Rosenberg S., Loskutoff D.J. Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? J. Cell. Biol. 134:1996;1563-1571.
8. Gimbrone M.A. Jr., Cybulsky M.I., Kume N., Collins T., Resnick N. Vascular endothelium. An integrator of pathophysiological stimuli in atherogenesis. Ann. N.Y. Acad. Sci. 748:1995;122-131.
9. Hermeking H., Lengauer C., Polyak K., He T.-C., Zhang L., Thiagalingam S., Kinzler K.W., Vogelstein B. 14-3-3tau is a p53-regulated inhibitor of G2/M progression. Molec. Cell. 1:1997;3-11.
10. Inoue S., Orimo A., Hosoi T., Ikegami A., Kozaki K., Ouchi Y., Nomura S., Muramatsu M., Orimo H. Demonstration of activin-A in arteriosclerotic lesions. Biochem. Biophys. Res. Commun. 205:1994;441-448.
11. Introna M., Breviario F., d'Aniello E.M., Golay J., Dejana E., Mantovani A. IL-1 inducible genes in human umbilical vein endothelial cells. Eur. Heart J. 14(Suppl. K):1993;78-81.
12. Jaffe E.A. Cell biology of endothelial cells. Hum. Pathol. 18:1987;234-239.
13. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52:1973;2745-2756.
14. Joshi-Barve S.S., Rangnekar V.V., Sells S.F., Rangekar V.M. Interleukin-1-inducible expression of gro-beta via NF-kappa B activation is dependent upon tyrosine kinase signaling. J. Biol. Chem. 268:1993;18018-18029.
15. Kojima I., Mogami H., Kawamura N., Yasuda H., Shibata H. Modulation of growth of vascular smooth muscle cells by activin A. Exp. Cell Res. 206:1993;152-156.
16. Kozian D.H., Ziche M., Augustin H.G. The activin-binding protein follistatin regulates autocrine endothelial cell activity and induces angiogenesis. Lab. Invest. 76:1997;267-276.
17. Lijnen H.R., Collen D. Endothelium in hemostasis and thrombosis. Prog. Cardiovasc. Diseases. 39:1997;343-350.
18. Madden S.L., Galella E.A., Zhu J., Bertelsen A.H., Beaudry G.A. SAGE transcript profiles for p53-dependent growth regulation. Oncogene. 15:1997;1079-1085.
19. McCarthy S.A., Bicknell R. Inhibition of vascular endothelial cell growth by activin-A. J. Biol. Chem. 268:1993;23066-23071.
20. Ny T., Sawdey M., Lawrence D., Millan J.D., Loskutoff D.J. Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor. Proc. Natl. Acad. Sci. USA. 83:1986;6776-6780.
21. Pannekoek H., Veerman H., Lambers H., Diergaard P., Verweij C.L., van Zonneveld A.J., van Mourik J.A. Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family. EMBO J. 5:1986;2539-2544.
22. Parhami F., Fang Z.T., Fogelman A.M., Andalibi A., Territo M.C., Berliner J.A. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J. Clin. Invest. 92:1993;471-478.
23. Polyak K., Xia Y., Zweier J.L., Kinzler K.W., Vogelstein B. A model for p53-induced apoptosis. Nature. 389:1997;300-305.
24. Risau W. Differentiation of endothelium. FASEB J. 9:1995;926-933.
25. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
26. Sambrook, J., Fritsch, E.F., Maniatis, T., 1989. Molecular Cloning, A Laboratory Manual. Cold Spring Harbor Laboratory Press, New York.
27. Slack J. Embryology: molecule of the moment. Nature. 349:1991;17-18.
28. Stefansson S., Lawrence D.A. The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin. Nature. 383:1996;441-443.
29. Steinbrecher U.P., Parthasarathy S., Leake D.S., Witztum J.L., Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA. 81:1984;3883-3887.
30. Ueno N., Nishimatsu S., Murakami K. Activin as a cell differentiation factor. Prog. Growth Factor Res. 2:1990;113-124.
31. Velculescu V.E., Zhang L., Vogelstein B., Kinzler K.W. Serial analysis of gene expression. Science. 270:1995;484-487.
32. Velculescu V.E., Zhang L., Zhou W., Vogelstein J., Basrai M.A., Bassett D.E. Jr., Hieter P., Vogelstein B., Kinzler K.W. Characterization of the yeast transcriptome. Cell. 88:1997;243-251.
33. Zhang L., Zhou W., Velculescu V.E., Kern S.E., Hruban R.H., Hamilton S.R., Vogelstein B., Kinzler K.W. Gene expression profiles in normal and cancer cells. Science. 276:1997;1268-1272.